Mobocertinib (TAK-788) in EGFR exon 20 insertion (ex20ins)+ metastatic non-small cell lung cancer (mNSCLC): Treatment (tx) beyond progressive disease (PD) in platinum-pretreated patients (pts) with and without intracranial PD Meeting Abstract
| Authors: | Janne, P. A.; Ramalingam, S. S.; Yang, J. C. H.; Riely, G. J.; Bunn, V.; Jin, S.; Zhou, C.; Camidge, D. R. |
| Abstract Title: | Mobocertinib (TAK-788) in EGFR exon 20 insertion (ex20ins)+ metastatic non-small cell lung cancer (mNSCLC): Treatment (tx) beyond progressive disease (PD) in platinum-pretreated patients (pts) with and without intracranial PD |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680302285 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.9099 |
| Notes: | Meeting Abstract: 9099 -- Meeting also held virtually -- Source: Wos |
